The cycloaddition between protonated glyoxylate imines possessing two chiral auxiliaries, N-(S)-or N-(R)-1-phenylethyl and (-)-8-phenylmenthyl or (+)-8-phenylneomenthyl, and cyclopentadiene is described. The absolute configuration of all adducts formed was unequivocally assigned through NMR, specific optical rotation and X-ray data of appropriated derivatives. Experimental results confirm the highly exoselectivity for these aza-Diels-Alder reactions, single adducts being obtained from combinations of (8PM)-(R-PEA) and (8PNM)-(S-PEA).
Introduction
The great versatility of cycloadditions, their high stereochemical control and the fair predictability of their regiochemistry allied to the rapid accumulation of polyfunctionality in a relatively small molecular framework, have contributed to the popularity of these reactions. 1 Within the diverse transformations comprising cycloadditions, aza-Diels-Alder reactions of imine derivatives and dienes leading to sixmembered aza-heterocycles, monocyclic and bicyclic molecules, have attracted much interest, especially those employing cyclopentadiene as starting material. 2, 3 The imines, used as aza-dienophiles, generally require activation by an electron-withdrawing group and a Lewis acid (LA) and/or Bronsted acid (BA) to participate in these [4+2] cycloaddition reactions. 3 It has been shown that the electronic nature of the substituents at the diene/dienophile pair may strongly influence the reaction pathways and determine either a concerted mechanism (synchronous or asynchronous) or a stepwise one. 4 In addition, experimentalists have always employed catalysts to change the kinetics of this class of reactions. In particular, a wide range of homogeneous and heterogeneous Lewis acids have been used to improve the rate and exo/endo selectivities of these cycloadditions.
2,3
The products obtained, 2-azabicyclo[2.2.1]hept-5-enes, 3 can be used as precursors of a large variety of compounds of chemical, biological and pharmaceutical interest. 5, 6 The products obtained in these reactions contain a highly functionalized bridged [2.2.1] ring system that may undergo further transformations (Scheme 1). Oxidation of the double bond, ring opening of the vicinal-diol, reduction or hydrolysis of the ester functionality would lead to a great number of chiral nonnatural amino alcohols and α-amino acids (pyrrolidine derivatives). Many of these "glycomimetics", also called azasugars, may
show useful activity as glycosidase inhibitors 7 with application as antiviral, 8 included potential nonnucleosidic inhibitors of HIV replication, 9 antineoplastic 10 and antidiabetic agents. 11 On the other hand, the sequence based on Barbier-Wieland degradation and the cleavage of the N-C 3 bond, would lead to chiral bicyclic lactams, useful as precursors of GABA analogs, 12 and chiral amino alcohols, derived from cyclopentene and cyclopentane, useful for the synthesis of carbocyclic nucleosides with antiviral and antineoplastic properties. Bailey and co-workers 14 investigated cycloadditions of (-)-8-phenylmenthyl (R)-and (S)-N-1-phenylethylimino glyoxylates with cyclopentadiene. The reaction showed high diastereoselectivity when the R-1-phenylethyl group was incorporated in the imine (>95%), and poor selectivitiy when the S-1-phenylethyl group was incorporated in the imine (<49%). The absolute configuration of the stereoisomers obtained was not determined, but the stereochemistry of the single product (bicycle) obtained in the case of the imine with the R-1-phenylethyl group was assumed to be (3S, exo), according to results obtained before by L. Stella and co-workers 3e with racemic methyl 1-phenylethylimine glyoxylate. Obviously, the reaction outcomes cannot be compared, as in one case (Bailey) 8-phenylmenthyl glyoxylate and in the other case (Stella) methyl glyoxylate was used. In fact, and as can be confirmed further in this paper, using 8-phenylneomenthyl glyoxylate and (R)-1-phenylethylamine (R-PEA) 3 diastereoisomers were obtained.
Our reasons to re-visit these reactions were first, to confirm the sterochemistry of these reactions for which no conclusive evidences had been apported before; and second, to enlarge the scope of these cycloadditions incorporating another menthyl chiral auxiliary, (+)-8-phenylneomenthyl, instead of the virtually inaccessible (+)-8-phenylmenthol (~ 500 euro/g), providing an alternative route to the obtention of the reverse adducts.
In a previous work on cycloadditions between chiral iminodienophiles of glyoxylates of 8-phenylmenthols and cyclopentadiene, we showed these reactions to be highly accelerated by the addition of a LA, due to the formation of an iminium cation complex that rapidly undergoes cycloaddition under mild conditions to give products with high stereo exo selectivity. 3c,3d,6b Herein we describe the most efficient synthesis of all the adducts formed in the cycloaddition of N-(S)-or N-(R)-1-phenylethylimines of (-)-8-phenylmenthyl or (+)-8-phenylneomenthyl glyoxylates, and cyclopentadiene. The assignement of the absolute configuration of all the adducts formed was achieved through NMR, specific optical rotation and X-ray data of the appropriated derivatives. In an attempt to explain this outcome we present in Scheme 3 a model for the approach of diene and dienophile. Taking into account, simultaneously, polar effects (hydrogen bonding) and repulsive interactions in the different conformations, the geometry corresponding to a syn-syn-syn alignment 3d is the one which best explains the obtention of the single adduct (1S,3exo) with the chiral auxiliaries 8-phenylmenthol/R-phenylethyl (attack on the si face) and the obtention of other single adduct (1R,3exo) with the chiral auxiliaries 8-phenylneomenthol/S-phenylethyl (attack on the re face). The high exoselectivity observed in these cases may be explained considering that: * the iminium ion, which acts as dienophile in the reaction, should have an E configuration, more stable for stereochemical (bulky groups far apart) and polar (hydrogen bonding C=O / N+-H) reasons.
Results and discussion
* in the close vicinity of the C=N bond, the 1-phenylethyl group exerts a larger steric hindrance than the ester group.
Consequently, in order to minimize stereochemical interactions (in the transition state)
between the methylene group of the diene and the bulky substituents of the dienophile, the approach diene-dienophile must occur in an exo manner. The stereochemical factors are more important than the secondary orbital interactions between the π systems of cyclopentadiene and the ester group in the dienophile. The configuration of the nitrogen atom in the final adduct is irrelevant, since it exists as a tertiary amine, after work up (HCO 3 -), capable of undergoing inversion of the lone pair of electrons to achieve the most stable conformation. In what concerns the preference observed in the approach of the diene to the diastereotopic faces of the dienophile, it is more difficult to suggest a hypothesis. The presence of two chiral auxiliaries and in particular the stereochemistry of the phenylethyl group must play an important role in the obtention of the single adducts, since the need for coplanarity of the benzene rings and for maximum distance of bulky substituents turns one of the diastereotopic faces much less hindered than the other. In the case of R-phenylethylamine, coplanarity of the benzene ring and maximum distance of this substituent from the phenylmenthyl group places the methyl group of the phenylethylamine backwards to the re-face and favors therefore highly attack from the less hindered si-face. In the case of S-phenylethylamine a similar rationalizing explains the preference for the re-face. Dihydroxylation of endo-cycloadduct 6a with OsO 4 in the presence of Nmethylmorpholine-N-oxide yielded diol 9 as crystals suitable for X-ray analysis ( figure   3 ). 19 In the case of endo-adduct 6b (1S,3endo), the absolute configuration was unequivocally determined from crystallographic data of X-ray diffraction of the corresponding ammonium trifluoroacetate 10 (1S,3endo) (figure 4). respectively. We have unambiguously the absolute configuration of all the adducts assigned, using NMR, specific optical rotation and X-ray data of the appropriated derivatives (amino alcohols 7, 3,5-dinitrobenzoates 8, diol 9 and ammonium trifluoroacetate 10).
Experimental

General Methods
All reactions were carried out under anhydrous conditions. Solvents were dried according to standard procedures and distilled prior to use. All reagents were commercially available and used without further purification, unless otherwise stated.
Flash column chromatography was performed on silica gel (60 Å, 230-240 mesh) and analytical thin-layer chromatography (TLC) on pre-coated silica gel 60 F 254 plates using iodine vapor and/or UV light (254 nm) for visualization. Melting points were determined on an electrothermal melting point apparatus and are uncorrected. Infrared spectra were recorded on FT/IR spectrophotometers and main bands are given in cm -1 .
The 1 H-NMR (300 MHz or 400 MHz) and 
General Procedure for the synthesis of acrylates (2a,2b)
3c,15d,e A solution of acryloyl chloride (2.10 mL, 25.8 mmol) in dry DCM (40 mL) was added drop wise under argon to a solution of 8-phenylmenthol (1a or 1b) (3.00 g, 12.9 mmol ), Et 3 N (3.6 mL; 26 mmol) and DMAP (227 mg, 1.81 mmol) in dry DCM (60 mL) at 0ºC.
The mixture was stirred for 2 hours at room temperature and was then treated with saturated NaHCO 3 solution (125 mL) and extracted with DCM (3 x 100 mL). The pooled organic layers were washed with saturated NaHCO 3 solution (2 x 100 mL) and brine (100 mL), and were then dried with Na 2 SO 4 . The solvent was removed in a rotary evaporator, and purification of the resulting residue on a short column of silica gel using Et 2 O:EtOAc 9:1 as eluent afforded the corresponding acrylate as a yellow oil. 
(-)-(1R,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl acrylate (2a).
(+)-(1S,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl acrylate (2b).
Yield ozone apparatus). Me 2 S (2 mL), was added and stirring was continued under argon for a further 12 h, time after which the solvent was evaporated and the residue extracted with DCM (3 x 100 mL). The pooled organic layers were washed with water (100 mL) and brine (100 mL) and dried over Na 2 SO 4 . Removal of the solvent in a rotary evaporator afforded a yellow oil, which was purified on a short column of silica gel using hexane:EtOAc 3:1 as eluent yielding the corresponding glyoxylate as a mixture of the glyoxylate and its hydrate which was used without further purification. meq.), water (9 mL) and dioxane (30 mL ) was stirred at rt for 5 min., time during 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 which the mixture became dark brown. Then NaIO 4 (3.51 g, 2eq.) was added in portions over 30 min, and the mixture (now pale brown) was stirred at room temperature for another 2 h and then extracted thoroughly with Et 2 O. The combined organic extracts were dried (Na 2 SO 4 ) and concentrated, affording a yellow oil that upon filtration through a short column of silica gel using hexane:EtOAc 3:1 as eluent afforded corresponding glyoxylate as a mixture of the glyoxylate and its hydrate which was used without further purification. After heating a small sample for 2 hours at 50 ºC under reduced pressure (10 -3 mmHg), the 1 H and 13 C-NMR spectra showed it to be essentially (> 85%) the anhydrous form of the corresponding glyoxylate.
(-)-(1R,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl glyoxylate (3a).
Yield: 97% (method A). Yield: 98% (method B).
An analytical sample of the mono-hydrate was obtained by recrystallization from hexane. = 3272, 2965, 1687, 1618, 1596, 1570, 1423, 1336, 1310, 1215, 1139, 1085, 1052, 920, 871, 834, 763, 742 = 3292, 3106, 2949, 1718, 1654, 1619, 1583, 1506, 1424, 1324, 1269, 1212, 1138, 1097, 918, 834, 758, 742 
(-)-(1R,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl glyoxylate hydrate.
M.p. 146-148ºC (hexane
(+)-(1S,2S,5R)-5-methyl-2-(1-methyl-1-phenylethyl)cyclohexyl glyoxylate (3b)
6
A solution of (R)-1-phenylethylamine (1.86 mL, 1.70 g, 14.0 mmol) in dry DCM (10 mL) was added drop wise under argon to a stirred suspension of (-)-8-phenylmenthyl glyoxylate (3a) (4.04 g, ca. 14.0 mmol) and 3Å molecular sieves (10 g) in dry DCM (50 mL) at 0ºC. The reaction mixture was stirred for 1 hour and then cooled to -78ºC and treated successively with TFA 1.08 mL, 1.60 g, 14.0 mmol), BF 3 .OEt 2 (1.77 mL, 1.99 g, 14.0 mmol) and freshly distilled cyclopentadiene (2.3 mL, ca. 28 mmol). After 5 h a mixture of saturated aqueous NaHCO 3 solution (28 mL) and then solid NaHCO 3 (3.3 g)
were added. The reaction mixture was allowed to reach room temperature and filtered through a pad of celite. The two layers were separated and the aqueous layer was extracted with DCM (3 x 100 mL). The aqueous layer was extracted with DCM (3 x 100 mL). The pooled organic layers were washed with saturated NaHCO 3 solution (3 x 100 mL) and brine (100 mL) and dried (Na 2 SO 4 ). Removal of the solvent on a rotavap yielded an orange oil which was purified by column chromatography (silica gel) using hexane:AcOEt 3:1 as eluent. Fractions 7-10 (R f 0.6.) afforded a colorless oil (5.09 g) identified as the pure single adduct (1R, 3exo) (5a1 
(+)-(1S,2S,5R)-8-phenylmenthyl (1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5b1).
Following the same procedure procedure as above, using (S)-1-phenylethylamine (1.88 g, 15.5 mmol) and (+)-8-phenylneomenthyl glyoxylate (3b) (4.47 g, ca. 15.5 mmol). 
(-)-(1R,2S,5R)-8-phenylmenthyl (1S,3S,4R)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5a2), (+)-(1R,2S,5R)-8-phenylmenthyl (1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5a3) and (-)-(1R,2S,5R)-8-phenylmenthyl (1R,3S,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (6a).
Following the same procedure as above, using (S)- = 3059, 2954, 1742, 1600, 1495, 1454, 1371, 1323, 1285, 1243, 1171, 1109, 1094, 1052, 1007, 918, 839, 765 = 3058, 2955, 1739, 1600, 1493, 1453, 1371, 1323, 1290, 1247, 1167, 1107, 1055, 1031, 1009, 917, 838, 763 = 3059, 2953, 1734, 1600, 1495, 1455, 1370, 1323, 1244, 1172, 1094, 1052, 1007, 910, 839, 765, 730 
(+)-(1S,2S,5R)-8-phenylneomenthyl (1R,3R,4S)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5b2), (-)-(1S,2S,5R)-8-phenylneomenthyl (1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (5b3) and (+)-(1S,2S,5R)-8-phenylneomenthyl (1S,3R,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate (6b).
Following the same procedure as above, using (R)-1-phenylethylamine (3.67 g, 30. 2924, 2869, 1738, 1716, 1662, 1600, 1449, 1370, 1276, 1245, 1218, 1169, 1147, 1109, 1080, 10, 32, 1005, 973 (dd, 1H, J 5.6 Hz, 1.6 Hz, H6), 6.45-6.51 (m, 1H, H5), 7.14-7.35 (m, 10H, Ph). 2948, 1737, 1601, 1494, 1453, 1368, 1324, 1246, 1222, 1190, 1166, 1146, 1108, 1078, 1057, 1032, 1006, 964, 922, 853, 830, 810, 757cm -1 . Anal. (8'-CH 3 ), 27.1 (C5'), 35.3 (C3'), 39.6 (C6'), 40.0 (C8'), 44.6 (C7), 48.4 (C4), 51.1 (C2'), 64.2 (C3), 64.5 (C1), 64.8 (CHPh), 71.7 (C1'), 125.5, 125.6, 126.0, 126.2, 126.9, 127.4, 127.9, 128.0, 128.2 and 128.4 (CH Ph ), 134.5 (C5), 139.2 (C6), 146.2 (C1 Ph-C8' ), 2926, 1738, 1658, 1599, 1578, 1494, 1447, 1370, 1317, 1276, 1175, 1148, 1115, 1073, 1029, 1000, 941, 919, 810, 762 
(+)-(1S,3R,4R)-2-[(1R)-1-phenylethyl)]-3-[(1S,2S,5R)-8-phenylneomenthyloxycarbonyl]-2-azabicyclo[2.2.1]hept-5-ene-2-ammonium trifluoroacetate (10).
Compound 6b (CF 3 COO), 125.66, 125.73, 125.80, 126.54, 126.68, 128.06, 128.42, 128.46, 128.74 NO: C 78.56, H 8.35, N 6.11; found: C 78.49, H 8.41, N 6 .02. NO: C 78.56, H 8.35, N 6.11; found: C 78.51, H 8.39, N 6.05 . Suitable crystals of (+)-(1R,3exo)-7A were obtained from hexane/Et 2 O and the structure was confirmed by the X-ray crystallographic analysis.
(+)-(1R
17,6b
(+)-(1R,3R,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-yl]methanol [(+)-7A] from 5b1.
Following the same procedure as above, using adduct 5b1 (2.00 g, 4.37 mmol). NO: C 78.56, H 8.35, N 6.11; found: C 78.50, H 8.38, N 6 .07.
(-)-(1S,3S,4R)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-yl]methanol [(-)-7A] from 5b3.
Following the same procedure as above, using adduct 5b3 (1.02 g, 2.23 mmol 3382, 3060, 2971, 2873, 1659, 1601, 1493, 1453, 1371, 1324, 1283, 1246, 1210, 1187, 1080, 1020, 912, 893, 831, 762 
(+)-(1R,3R,4S)-2-[(1R)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-yl]methanol [(+)-7B] from 5b2.
Following the same procedure as above, using adduct 5b2 (1.07 g, 2.34 mmol NO: C 78.56, H 8.35, N 6.11; found: C 78.52 H 8.38, N 6 .12.
(-)-(1R,3S,4S)-2-[(1S)-1-phenylethyl)]-2-azabicyclo[2.2.1]hept-5-en-3-yl]methanol [(-)-7C] from endo-6a.
Following the same procedure as above, using adduct 6a (2.02 g, 4.41 mmol = 2974, 1723, 1684, 1653, 1629, 1541, 1457, 1343, 1280, 1169, 1136, 1074, 964, 913, 770, 729, 702 A solution of adduct (-)-6a (0.60 g, 1.3 mmol), NMO (0.21 g, 1.01 eq.) and OsO 4 (1,5 mL, 0.0039 M sol. in water, 0.45 mol %) in tert-butanol/THF/water 9:15:1 (7 mL) was stirred at ambient temperature under argon for 1 hour. The reaction mixture was then filtered through a celite pad and washed with THF. Removal of the solvent on a rotavapor yielded a bordeaux residue which was purified by column chromatography (silica gel) using hexane: EtOAc 3:2 as eluent. Fractions 3-9 (R f 0.35) afforded a light pink oil (0.50 g) which solidified on standing and which was identified as the dihydroxylated adduct (-)-9. Yield 79%. Suitable white crystals of (-)-9 were obtained from hexane/EtOAc and the structure was confirmed by X-ray crystallographic 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 
(-)-(1S,3S,4R)-2-[(1R)-1-phenylethyl)]-
